PharmaLex Group has completed its merger with CompliMed in the United Kingdom. CompliMed is the UK’s leading Healthcare Compliance Consultancy specialising in the ABPI Code of Practice.
UK-based international healthcare communications agency Makara Health has made a number of appointments to its team, including new digital strategy director Ekta Rohra (pictured above).
Roche's Alecensa has been recommended for routine NHS use as an adjuvant treatment for ALK-positive non-small cell lung cancer (NSCLC), the first targeted therapy for this indication.